Mereo BioPharma Group plc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC MREO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,763,666

Value ($000)

735

Weight

0.0%

2024 Q4 - 2025 Q4 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	735	0.0%	1,763,666	12/31/2025
2025 Q3	11/14/2025	3,928	0.0%	1,906,775	9/30/2025
2025 Q1	5/19/2025	3,530	0.0%	1,569,100	3/31/2025
2024 Q4	2/14/2025	3,377	0.0%	964,900	12/31/2024